Business
Press Release Jun 02 2021
Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled \"Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.\". View Attachment","length":341,"tagName":"div"}]